Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

BioPorto – Presentation of Half-Year Report 2023

BIOPOR2023-08-01 14:00
HC Andersen Capital

Meet and ask questions to BioPorto CEO Tony Pare and CFO Neil Goldman on Tuesday 1 August at 2.00 PM CEST when they present the financial results for the first six months of 2023 along with the latest development for the NGAL Test and the outcome of the rights issue successfully completed in June 2023.

Disclaimer: HC Andersen Capital receives payment from Bioporto for a Digital IR/Corporate Visibility subscription agreement. /ANALYST Claus Thestrup 15:15 PM 5 July 2023.

Upcoming webcasts

Recent videos

Autopsy of the previous IPO cycle | Heikkilä & Vilén Show 94
2026-09-18 13:52
Higher-quality companies can be found in Europe than people think | inderesPodi 260
2026-09-18 09:32
AI concerns and interest rate anxiety | Verneri's Quarter Hour
2026-09-17 09:14
Nightingale Health H2'26: Projects are progressing
2026-09-16 15:57 Nightingale Health
Nightingale Health 2025–2026 Results Webcast
2026-09-16 13:00 Nightingale Health
View all videos